2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide

C57H78N10O17S2 — CID 158508335

IUPAC2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide
SMILESCC[C@H](C)[C@@H]1CC(=O)CNC(=O)[C@H]2CC(=O)[C@H]([C@@H](C)[C@@H](O)CO)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS(=O)c3[nH]c4c(CS[C@@H]5CCN(C(=O)CCCCCN6C(=O)C=CC6=O)C5)c(OC)ccc4c3C2)NC(=O)CNC1=O
InChIInChI=1S/C57H78N10O17S2/c1-5-29(2)36-19-32(69)22-59-52(78)31-17-37-35-10-11-44(84-4)38(27-85-34-14-16-65(25-34)47(75)9-7-6-8-15-66-48(76)12-13-49(66)77)51(35)64-56(37)86(83)28-40(61-46(74)23-60-53(36)79)54(80)62-39(21-45(58)73)57(82)67-24-33(70)20-41(67)55(81)63-50(42(71)18-31)30(3)43(72)26-68/h10-13,29-31,33-34,36,39-41,43,50,64,68,70,72H,5-9,14-28H2,1-4H3,(H2,58,73)(H,59,78)(H,60,79)(H,61,74)(H,62,80)(H,63,81)/t29-,30-,31+,33+,34+,36-,39-,40-,41-,43-,50-,86?/m0/s1
InChIKeyHKSVKVHRGUQMIS-WMKJFHMPSA-N
MW1239.44 g/mol
LogP-2.12
Rot. Bonds17

About 2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide

2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide (PubChem CID 158508335) has the molecular formula C57H78N10O17S2 and a molecular weight of 1239.44 g/mol. Its IUPAC name is 2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide.

Molecular Properties

Compound Name2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide
PubChem CID158508335
Molecular FormulaC57H78N10O17S2
Molecular Weight1239.44 g/mol
Exact Mass1238.50
IUPAC Name2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide
SMILESCC[C@H](C)[C@@H]1CC(=O)CNC(=O)[C@H]2CC(=O)[C@H]([C@@H](C)[C@@H](O)CO)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS(=O)c3[nH]c4c(CS[C@@H]5CCN(C(=O)CCCCCN6C(=O)C=CC6=O)C5)c(OC)ccc4c3C2)NC(=O)CNC1=O
InChIInChI=1S/C57H78N10O17S2/c1-5-29(2)36-19-32(69)22-59-52(78)31-17-37-35-10-11-44(84-4)38(27-85-34-14-16-65(25-34)47(75)9-7-6-8-15-66-48(76)12-13-49(66)77)51(35)64-56(37)86(83)28-40(61-46(74)23-60-53(36)79)54(80)62-39(21-45(58)73)57(82)67-24-33(70)20-41(67)55(81)63-50(42(71)18-31)30(3)43(72)26-68/h10-13,29-31,33-34,36,39-41,43,50,64,68,70,72H,5-9,14-28H2,1-4H3,(H2,58,73)(H,59,78)(H,60,79)(H,61,74)(H,62,80)(H,63,81)/t29-,30-,31+,33+,34+,36-,39-,40-,41-,43-,50-,86?/m0/s1
InChIKeyHKSVKVHRGUQMIS-WMKJFHMPSA-N
XLogP-2.12
TPSA403.51 Ų
H-Bond Donors10
H-Bond Acceptors18
Rotatable Bonds17
Heavy Atoms86
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001239.44
LogP ≤ 5-2.12
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide?
The IUPAC name of 2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide (CID 158508335) is 2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide.
What is the SMILES notation for 2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide?
The canonical SMILES for 2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide is CC[C@H](C)[C@@H]1CC(=O)CNC(=O)[C@H]2CC(=O)[C@H]([C@@H](C)[C@@H](O)CO)NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS(=O)c3[nH]c4c(CS[C@@H]5CCN(C(=O)CCCCCN6C(=O)C=CC6=O)C5)c(OC)ccc4c3C2)NC(=O)CNC1=O.
What is the InChIKey of 2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide?
The InChIKey is HKSVKVHRGUQMIS-WMKJFHMPSA-N. The full InChI is InChI=1S/C57H78N10O17S2/c1-5-29(2)36-19-32(69)22-59-52(78)31-17-37-35-10-11-44(84-4)38(27-85-34-14-16-65(25-34)47(75)9-7-6-8-15-66-48(76)12-13-49(66)77)51(35)64-56(37)86(83)28-40(61-46(74)23-60-53(36)79)54(80)62-39(21-45(58)73)57(82)67-24-33(70)20-41(67)55(81)63-50(42(71)18-31)30(3)43(72)26-68/h10-13,29-31,33-34,36,39-41,43,50,64,68,70,72H,5-9,14-28H2,1-4H3,(H2,58,73)(H,59,78)(H,60,79)(H,61,74)(H,62,80)(H,63,81)/t29-,30-,31+,33+,34+,36-,39-,40-,41-,43-,50-,86?/m0/s1.
What are the key properties of 2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide?
2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide has a molecular weight of 1239.44 g/mol, XLogP of -2.12, 17 rotatable bonds, 10 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(1R,4S,8R,10S,13S,16R,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-23-[[(3R)-1-[6-(2,5-dioxopyrrol-1-yl)hexanoyl]pyrrolidin-3-yl]sulfanylmethyl]-8-hydroxy-22-methoxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,25,29,32,38-heptazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide is sourced from PubChem (CID 158508335), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).